SA’s medicines regulator has turned down Lamar Internationals’ emergency use authorisation application for Russia’s Sputnik V Covid-19 vaccine, saying it is concerned the jab may increase the risk of men becoming infected with HIV.

The SA Health Products Regulatory Authority (Sahpra) said previous studies found vaccines containing the adenovirus type 5 vector (Ad5), which is included in Sputnik V, increased the risk of HIV acquisition. SA has the world’s highest HIV burden, with an estimated 8.2-million people living with the virus...

Subscribe now to unlock this article.

Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).

There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.

Cancel anytime.

Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.

Speech Bubbles

Please read our Comment Policy before commenting.